Browse EX-10 agreements

TRANSITION SERVICES AGREEMENT

This Transition Services Agreement (this “Agreement”) is made and entered into by and between Sam Hinrichsen (“Hinrichsen”) and Lindsay Corporation, a Delaware corporation (the “Company”) to become effective on the Effective Date (as defined in Section 14), on the terms and subject to the conditions set forth herein.

RECITALS

WHEREAS, Hinrichsen currently serves as Senior Vice President and Chief Financial Officer of the Company, but has notified the Company of his intention to leave the Company for personal reasons, with his employment to terminate effective August 31, 2026;

WHEREAS, in order to assure access to Hinrichsen’s unique and valuable services and an effective leadership transition, the Company desires to retain Hinrichsen to provide transition services for a specified transition period on the terms and conditions set forth herein; and

WHEREAS, Hinrichsen agrees to provide transition services to the Company during the specified transition period on the terms and conditions set forth herein;

…

Execution Version

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

GM FINANCIAL CONSUMER AUTOMOBILE RECEIVABLES TRUST 2026-3,

Issuer

AMERICREDIT FINANCIAL SERVICES, INC.

D/B/A GM FINANCIAL,

Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,

Asset Representations Reviewer

Dated as of July 15, 2026

---

TABLE OF CONTENTS

| | | | | | | | | ------------------------------------------------------- | - | ----------------------------------------------------------- | : | - | -: | - | | | | | | | | | | ARTICLE I DEFINITIONS | | | | | 1 | | | Section 1.1. | | Definitions | | | 1 | |

…

Execution Version

**PURCHASE AGREEMENT **

**between **

**AFS SENSUB CORP. **

**Purchaser **

**and **

**AMERICREDIT FINANCIAL SERVICES, INC. **

**D/B/A GM FINANCIAL **

**Seller **

**Dated as of July 15, 2026 **

---

**TABLE OF CONTENTS **

| | | | | | | | | ----------------------------------------------------------------------------- | - | --------------------------------------------------------------------------- | : | :---: | -----: | ----- | | | | | | | | | | | | | | Page | | |

…

DEEP FISSION, INC.

2025 Equity Incentive Plan, as Amended

	1.	General

(a)            Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.

(b)            Available Awards. The Plan provides for the grant of the following Awards: (i) Incentive Stock Options; (ii) Nonstatutory Stock Options; (iii) SARs; (iv) Restricted Stock Awards; (v) RSU Awards; (vi) Performance Awards; and (vii) Other Awards.

(c)            Adoption Date; Effective Date. The Plan will come into existence on the Adoption Date, but no Award may be granted prior to the Effective Date.

…

EXECUTION COPY

FOURTH AMENDMENT
TO SENIOR SECURED REVOLVING CREDIT AGREEMENT

THIS FOURTH AMENDMENT TO SENIOR SECURED REVOLVING CREDIT AGREEMENT, dated as of July 14, 2026 (this “Amendment”), to the Existing Credit Agreement (capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in Article I) is among BAIN CAPITAL PRIVATE CREDIT, a Delaware statutory trust (the “Borrower”), solely with respect to Section 5.12herein, the SUBSIDIARY GUARANTORS party hereto, the LENDERS and ISSUING BANKS party hereto and SUMITOMO MITSUI BANKING CORPORATION, as Administrative Agent (the “Administrative Agent”) and, solely with respect to Section 5.11herein, as Collateral Agent (the “Collateral Agent”).

W I T N E S S E T H:

…

CORPORATE INTEGRITY AGREEMENT BETWEEN THE

OFFICE OF INSPECTOR GENERAL OF THE

DEPARTMENT OF HEALTH AND HUMAN SERVICES AND

EYEPOINT INC.

I.

PREAMBLE

EyePoint Inc. and all subsidiaries and any additional affiliated entities owned, controlled, or operated by EyePoint Inc. including those that may be created during the term of this CIA (collectively, “Entity”) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements) and written directives of the Food and Drug Administration (FDA requirements). Contemporaneously with this CIA, Entity is entering into a Settlement Agreement with the United States.

II.

EFFECTIVE DATE, TERM, AND DEFINITIONS

A.

…

SETTLEMENT AGREEMENT

This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services (“OIG‑HHS”) and the Defense Health Agency (“DHA”), acting on behalf of the TRICARE Program, (collectively, the “United States”); EyePoint, Inc. (“EyePoint”); and AFCE LLC (hereafter collectively referred to as “the Parties”), through their authorized representatives.

RECITALS

A. EyePoint, Inc. (formerly EyePoint Pharmaceuticals, Inc.) is a pharmaceutical company headquartered in Massachusetts and incorporated under the laws of Delaware. EyePoint is a bio-therapeutic company which develops and commercializes treatments for eye diseases.

…

REGISTRATION RIGHTS AGREEMENT

among

CSQUARE, INC.

AND

THE HOLDERS PARTY HERETO

DATED July 17, 2026

TABLE OF CONTENTS

Page

ARTICLE I DEFINITIONS		1
Section 1.1	Definitions	1
ARTICLE II DEMAND AND SHELF REGISTRATION		5

…

STOCKHOLDERS AGREEMENT

by and among

CSQUARE, INC.

and

THE OTHER PARTIES HERETO

Dated as of July 17, 2026

TABLE OF CONTENTS

Page

Article** I** INTRODUCTORY MATTERS		1
Section 1.1	Defined Terms	1
Section 1.2	Construction	4
Article** II** BOARD OF DIRECTORS		5
Section 2.1	Election of Directors	5

…

---

CNL Strategic Residential Credit, Inc. 8-K 

Exhibit 10.1

GUARANTY AGREEMENT

This GUARANTY AGREEMENT (this “Guaranty Agreement”) is entered into as of July 17, 2026, made by CNL Strategic residential credit, inc., a Maryland corporation, as Guarantor, (the “Guarantor” ) for the benefit of GOLDMAN SACHS BANK USA, as Buyer (in such capacity, “Buyer”) and as Repo Agent (in such capacity, “Repo Agent”). Unless otherwise defined herein or in Exhibit A hereto, capitalized terms used herein shall have the meanings given to them in the Repurchase Agreement (as defined below).

W I T N E S E T H :

WHEREAS, Buyer, Repo Agent and RCRED Craftsman Administrator, LLC, as seller (in such capacity, “Seller”) and as administrator (in such capacity, the “Administrator”) entered into that certain Master Repurchase Agreement dated as of the date hereof (as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, the “Repurchase Agreement”);

…

WIND-DOWN AND DISTRIBUTION AGREEMENT

This Wind-Down and Distribution Agreement (the “Agreement”) dated July 14, 2026 (the “Execution Date”) is by and among (i) Optimus Healthcare Services, Inc. (“Optimus” or the “Company”); (ii) Arena Special Opportunities Fund, LP, Arena Special Opportunities Partners, I, LP, and Arena Special Opportunities Partners, II, LP (the “Purchasers”); and (iii) Arena Investors, LP (“Arena Investors”) for itself and as agent for the Purchasers (Arena Investors together with the Purchasers, “Arena”) (each a “Party,” and together, the “Parties”).

WITNESSETH:

** **

WHEREAS, on May 25, 2021, Arena entered into a Securities Purchase Agreement with Optimus by which the Company issued to the Purchasers two-year Original Issue Discount Senior Secured Convertible Promissory Notes for the aggregate principal amount of $2,200,000 (the “May 2021 Notes”);

…

** **

AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT

** **

THIS AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT (this “Amendment No. 2”) is dated as of July [__], 2026, by and among Aditxt, Inc., a Delaware corporation (the “ADTX Borrower”), Ignite Proteomics LLC, a Delaware limited liability company (the “Ignite Borrower”, and together with the ADTX Borrower, the “Borrowers”) and the undersigned Buyers (as defined in the Note Purchase Agreement (as defined below)) (collectively, the “Undersigned Buyers”), and, subject to the occurrence of the Effective Time, will amend that certain Note Purchase Agreement, dated as of June 3, 2026, by and among the Borrowers and each of the Buyers (the “Note Purchase Agreement”), as amended by that certain Amendment No. 1 to Note Purchase Agreement, dated June 22, 2026 (“Amendment No. 1”). Capitalized terms used herein but not otherwise defined herein shall have the respective meanings set forth in the Note Purchase Agreement.

…